Saturday 17 October 2026 Export ITGR’s income statement to Excel — free account

Integer Holdings Corporation

Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024. In the quarter to June 2026, revenue fell 2.60%, EPS fell 34.9%, free cash flow grew 48.8% and total debt rose 4.96%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

126.70 0.02 −0.02%

Follow ITGR

Alert me

Market cap: $4.3B
P/E: 34.3×
Fwd P/E: 27.6×
Dividend yield: —
F-score: 6/9
Altman Z: 2.34
Beneish M: −2.30
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.30

Total sells 5.30

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	3	—	—	—	—	—	—	—	—	—	—	—
Sell	1	—	—	—	1	—	—	—	—	—	2	—

Insider Ownership 0.68%

Capital & Financial Ratios $m

Market Cap 4,310.00

Revenue 1,843.44

Net Income 128.40

Free Cash Flow 111.98

Net Debt 1,267.80

Current Ratio 3.73

Debt/Equity 0.75

P/E ratio 34.34

Fwd P/E 27.60

P/S ratio 2.34

P/B ratio 2.51

Past 5Y EPS Growth 4.40%

This Y EPS Growth (3.85%)

Next Y EPS Growth 11.50%

Next Y revenue growth (1.76%)

Next 5Y EPS Growth 4.53%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 58.11%

10-year low 10-year high

P/S against its own 10 years 78.40%

10-year low 10-year high

P/B against its own 10 years 85.92%

10-year low 10-year high

EV/Sales against its own 10 years 71.07%

10-year low 10-year high

EV/FCF against its own 10 years 71.31%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	24	47	17	21
Receivables	231	245	346	339
Inventory	229	247	254	288
Other	86	104	113	119
	618	671	770	811

	2023	2024	2025	Q'26
Payables	118	101	113	112
ST’ Debt	—	10	—	—
Other	—	—	—	—
	221	227	232	217

Compound Annual Growth %

	10y	5y	3y
Sales	8.76%	11.54%	11.67%
Cash Flow	31.72%	1.58%	19.01%
Earnings	0.00%	5.88%	15.70%
Book Value	7.46%	6.56%	7.21%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	440	464	—	—	—
’25	437	476	468	472	1,854
’24	408	428	431	449	1,717
’23	379	400	397	380	1,556
’22	311	350	343	328	1,331
’21	290	312	306	313	1,221
’20	328	240	236	269	1,073

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	25	60	—	—	—
’25	31	44	66	55	196
’24	23	47	72	63	205
’23	6	56	62	56	180
’22	18	19	28	52	116
’21	36	32	49	39	157
’20	32	46	32	71	181

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	1	37	—	—	—
’25	6	25	46	28	105
’24	(6)	16	45	44	100
’23	(19)	23	37	18	60
’22	8	7	7	20	42
’21	29	22	37	16	104
’20	14	33	23	59	130

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.48	0.69	—	—	—
’25	(0.66)	1.04	1.11	1.38	2.89
’24	0.59	0.88	0.99	0.90	3.36
’23	0.39	0.71	0.81	0.78	2.69
’22	0.34	0.62	0.48	0.54	1.99
’21	0.65	0.89	0.66	0.71	2.91
’20	0.94	0.01	0.92	0.47	2.33

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	18.10	29.00	42.50	67.72	46.01	73.32	50.05	63.00	94.56	62.00	Analyst estimates 2026–2028 Powerpack
	High	47.77	55.20	90.03	92.62	99.95	101.61	88.58	100.99	142.76	146.36
People
People	Employees	9,400	9,700	8,250	8,250	7,500	9,000	10,000	10,500	11,000	11,000
	Revenue/emp, $m	0.11	0.12	0.15	0.15	0.14	0.14	0.13	0.15	0.16	0.17
Income, $m
Income, $m	Revenue	1,076	1,136	1,215	1,258	1,073	1,221	1,331	1,556	1,717	1,854
	Gross margin, %	31.40	31.16	29.85	28.22	26.62	27.60	25.97	26.35	26.74	26.99
	EBT	28	49	61	105	86	101	69	105	148	125
	EBT margin, %	2.62	4.34	5.03	8.36	8.03	8.28	5.16	6.77	8.60	6.76
	Net income	6	67	168	96	77	97	66	91	120	103
	Depreciation	98	114	138	86	84	88	94	107	115	138
Per share, $
Per share, $	Revenue	34.94	36.18	37.81	38.56	32.68	37.01	40.19	46.69	51.09	53.37
	Earnings	0.19	2.12	5.23	2.95	2.35	2.93	2.00	2.72	3.57	2.96
	Cash flow	3.43	4.76	5.21	5.07	5.52	4.75	3.51	5.41	6.11	5.65
	Capex	(1.89)	(1.49)	(1.35)	(1.48)	(1.56)	(1.61)	(2.24)	(3.60)	(3.14)	(2.62)
	Free cash flow	1.54	3.27	3.85	3.59	3.96	3.14	1.28	1.81	2.96	3.03
	Book value	23.56	28.45	33.00	35.32	38.70	41.06	42.79	45.59	48.19	50.28
	Shares, m	31	31	32	33	33	33	33	33	34	35
Valuation, ×
Valuation, ×	P/E	155.53	21.62	14.67	27.17	34.55	29.21	34.24	36.12	37.22	26.86
	P/S	0.85	1.25	2.02	2.09	2.48	2.31	1.70	2.10	2.59	1.47
	P/B	1.25	1.60	2.31	2.28	2.10	2.08	1.60	2.15	2.75	1.56
	EV/Sales	2.41	2.64	2.76	2.72	3.12	2.98	2.39	2.72	3.16	2.12
	EV/FCF	54.77	29.24	27.07	29.23	25.76	36.77	84.31	75.98	54.83	37.66
Cash, $m
Cash, $m	Operating cash flow	106	149	167	165	181	157	116	180	205	196
	Capex	(58)	(47)	(44)	(48)	(51)	(53)	(74)	(120)	(106)	(91)
	Free cash flow	47	103	124	117	130	104	42	60	100	105
Balance, $m
Balance, $m	Working capital	332	323	252	236	257	293	335	397	444	538
	Total debt	1,730	1,609	926	815	731	836	933	970	1,014	1,214
	Net debt	1,678	1,572	900	801	682	818	909	947	967	1,197
	Shareholders’ equity	725	893	1,060	1,152	1,271	1,355	1,417	1,519	1,619	1,747
Returns, %
Returns, %	ROA	0.21	2.35	6.49	4.12	3.27	3.91	2.47	3.16	3.98	3.17
	ROIC	2.42	3.19	4.96	5.04	3.86	3.90	3.03	4.14	5.03	4.70
	ROE	0.76	8.24	17.19	8.71	6.38	7.37	4.79	6.17	7.64	6.11

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
BRKR Bruker Corporation	$8.6B	— (loss-making)	55.7×	+5.15% (above 0%: growing)	n/m	+28.63% (above 0%: growing)	49.61%	(7.79%)	Compare
HAE Haemonetics Corporation	$5.5B	57.7×	18.0×	+5.60% (above 0%: growing)	+2.86% (above 0%: growing)	+220.38% (above 0%: growing)	59.76%	16.93%	Compare
LIVN LivaNova PLC	$4.3B	22.5×	26.0×	+10.80% (above 0%: growing)	+296.00% (above 0%: growing)	−26.66% (below 0%: shrinking)	70.07%	12.67%	Compare
ITGR Integer Holdings Corporation	$4.3B	34.3×	27.6×	−2.60% (below 0%: shrinking)	−34.91% (below 0%: shrinking)	+48.81% (above 0%: growing)	24.34%	7.44%
IRTC iRhythm Holdings, Inc.	$3.6B	— (loss-making)	— (loss-making)	+20.08% (above 0%: growing)	n/m	+116.98% (above 0%: growing)	72.80%	(1.13%)	Compare
NEOG Neogen Corporation	$2.7B	— (loss-making)	— (loss-making)	+6.51% (above 0%: growing)	n/m	+135.75% (above 0%: growing)	47.35%	(0.81%)	Compare
TMDX TransMedics Group, Inc.	$2.7B	16.0×	34.1×	+20.70% (above 0%: growing)	−59.22% (below 0%: shrinking)	−87.62% (below 0%: shrinking)	59.59%	12.50%	Compare
UFPT UFP Technologies, Inc.	$2.3B	31.2×	23.6×	+15.07% (above 0%: growing)	+20.63% (above 0%: growing)	−35.77% (below 0%: shrinking)	29.27%	16.15%	Compare
BFLY Butterfly Network, Inc.	$2.1B	— (loss-making)	— (loss-making)	+39.47% (above 0%: growing)	n/m	−113.85% (below 0%: shrinking)	71.41%	(41.90%)	Compare
Median of peers	$3.1B	26.8×	26.0×	+12.94%	+11.75%	+0.98%	59.68%	5.85%

All 149 Medical Devices stocks →

Integer Holdings Corporation (ITGR) key facts

Strength: Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
Integer Holdings Corporation (ITGR) is a Medical Devices company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, ITGR traded at $126.70, a market capitalization of $4.3 billion.
Return on equity was 6.11% and debt-to-equity 0.75.
Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 2.34 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.